Consulting
We provide strategic planning and advisory services to clients in the pharmaceutical and health care industries. We also consult with law firms, industry trade associations, private equity firms, and institutional investors. Dr. Adam J. Fein is fully involved in all assignments.
Our work helps executives and managers to improve strategic decision making by providing relevant information, analyses, or insights about pharmacy economics and the pharmaceutical supply chain. Here are some representative topics for which clients have engaged us:
-
Contracting strategies with pharmaceutical wholesalers
-
Managing the convergence of retail pharmacy and PBM companies
-
Predicting the future developments of pharmaceutical wholesaler fee-for-service agreements with manufacturers
-
Providing business model and financial analyses of drug channel intermediaries (distribution, dispensing, and financial/contracting)
-
Evaluating options for managing the order-to-cash activities during the launch phase of an innovative new pharmaceutical product
-
Developing scenarios for the future of the retail pharmacy industry
In addition, Dr. Fein personally advises institutional investors on pharmaceutical industry issues through an exclusive affiliation with Gerson Lehrman Group (GLG). GLG clients can request a consultation with Dr. Fein via his GLG web page.
